| Document |
Document Title |
|
WO/2022/270143A1 |
The present invention provides a novel compound which can have the property of being specifically taken into cancer cells. Produced in the present invention is a novel 4-borono-phenylalanine derivative, a borono-phenylalanine derivative ...
|
|
WO/2022/267721A1 |
The present invention relates to a series of organic electroluminescent materials containing B-N fused rings. The structures of the organic electroluminescent materials are represented by formula (I), and have 100% internal quantum effic...
|
|
WO/2022/270592A1 |
This compound represented by a general formula is useful as an electron barrier material. R1 through R5 are a deuterium atom, a substituent other than a cyano group; n1, n3, n5 are 0-4; n2 is 0-3; n4 is 0-2; X is O or S; and Ar is a mono...
|
|
WO/2022/270600A1 |
An organic light emitting element which comprises compounds represented by the general formulae has excellent light emission characteristics. In the general formulae, one of X1 and X2 represents N, and the other represents B; R1 to R26, ...
|
|
WO/2022/270113A1 |
Provided is an organic electroluminescent element by which high light-emission efficiency can be obtained even in a case in which the LUMO level of a fluorescent material is lower than the LUMO level of a delayed fluorescent material. Th...
|
|
WO/2022/270591A1 |
An organic light emitting element which uses a compound represented by the general formula has high thermal stability and excellent light emission characteristics. Each of R1 to R7 represents a hydrogen atom, a deuterium atom, an alkyl g...
|
|
WO/2022/270878A1 |
A perovskite composite, according to one embodiment of the present disclosure, comprises: perovskite (AMX3) containing an organic cation (A), a metal cation (M), and a halogen anion (X); and methylammonium chloride (MACl) (CH3NH3Cl), whe...
|
|
WO/2022/223848A9 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure represented by formula IVf wherein X is independently selected fr...
|
|
WO/2022/262057A1 |
An organic electroluminescent material and a preparation method therefor, the organic electroluminescent material comprising diboronanthracene fluoride, and the organic electroluminescent material having a low single triplet energy level...
|
|
WO/2022/263800A1 |
The invention relates to a process for synthesising organic molecules. The invention provides a process for forming an sp2-sp3 carbon-carbon bond between a first compound comprising a substituted or unsubstituted aromatic group and a sec...
|
|
WO/2022/263801A1 |
The present invention relates to a process for the preparation of a compound of formula (VI), or a salt or derivative thereof, comprising reacting a compound of formula (V) with a compound of formula (IX) wherein R2, R4, R5 and Z are as ...
|
|
WO/2022/262063A1 |
Embodiments of the present application provide a fluorescent material. The fluorescent material has a molecular structure combining an electron donor and an electron acceptor. On the basis of a structure of combined triphenylborane and t...
|
|
WO/2022/264114A2 |
The invention described herein provides a reactive oxygen species (ROS) responsive linker based on diazaborines (DAB) scaffold. Here we show the ability of diazaborines (DABs) scaffolds to be stable in different biocompatible conditions ...
|
|
WO/2022/260163A1 |
The compound of one aspect of the present invention is represented by formula (1). R1 represents an aryl group that has one or more alkoxy groups, when the aryl group has two or more alkoxy groups, it being possible for at least two of t...
|
|
WO/2022/252200A1 |
A three-dimensional rare earth terbium compound, a synthesis method therefor, and an application thereof, relating to the technical field of fluorescent sensing materials. The method comprises, in the presence of an aqueous solvent, mixi...
|
|
WO/2022/255837A1 |
The present invention relates to: a method for manufacturing an organometallic compound (in particular, an organometallic compound including rare earth metal); and a method for manufacturing a thin film that has excellent properties by d...
|
|
WO/2022/255634A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2022/250254A1 |
The present invention relates to: a crosslinking agent for a quasi-solid electrolyte, the agent being a polyester derivative comprising boron at the center thereof; a quasi-solid electrolyte using the crosslinking agent for a quasi-solid...
|
|
WO/2022/250776A1 |
Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the...
|
|
WO/2022/250400A1 |
The present invention relates to a semiconductor thin film-forming metal precursor compound represented by chemical formula 1 and a metal-containing thin film formed using same.
|
|
WO/2022/243468A1 |
A method of forming a single-ion conductive network comprising reaction of a first compound of formula (I) with a second compound and a third compound: formula (I). X is selected from the group consisting of B and Al. M+ is a cation, e.g...
|
|
WO/2022/244971A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2022/246210A1 |
A targeted radiopharmaceutical of chemical Formula I, below, is disclosed wherein Q+3 is a trivalent radioactive isotope ion; M is a proton (H+), an ammonium ion or an alkali metal ion; "g" is a number that is 1 to about 12; the boxed mA...
|
|
WO/2022/242437A1 |
A fluorescence-magnetic resonance bimodal contrast agent, a preparation method therefor and the use thereof. The contrast agent has the following structure: X-L-Y, wherein: formula (I); R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R1...
|
|
WO/2022/243470A2 |
A compound of formula (I): (I) wherein X is Al or B; R1 in each occurrence is independently a substituent; and two R1 groups may be linked to form a ring; and M+ is a cation. The compound may be used in a metal ion battery or metal battery.
|
|
WO/2022/237668A1 |
The present invention relates to the technical field of semiconductors, and disclosed in the present invention are a fused ring compound, an application thereof, and an organic electroluminescent device containing same. Such a fused ring...
|
|
WO/2022/236278A1 |
Nuclear targeting tags having a phenylboronate targeting moiety, a linker, a chemically linkable end group suitable for linking the targeting moiety to a molecule of interest, and optionally a spacer between the linker and chemically lin...
|
|
WO/2022/233795A1 |
The present application relates to substituted dyes containing bis-boron fused heterocycles and their uses as fluorescent labels. These compounds may be used as fluorescent labels for nucleotides in nucleic acid sequencing applications.
|
|
WO/2022/230793A1 |
The purpose of the present invention is to provide a compound that promotes the maintenance and multiplication of hematopoietic stem cells, and is useful in the cultivation and similar of hematopoietic stem cells that can be used in hema...
|
|
WO/2022/230643A1 |
The polycyclic aromatic compound according to one embodiment of the present invention is a compound which, when subjected to excitation light, emits observable light, exhibits a peak wavelength region between 500 nm and 750 nm where the ...
|
|
WO/2022/231410A1 |
The invention relates to new radiopharmaceuticals that inhibit fibroblast activation protein (iFAP), which are based on the molecule ((R)-1-((6-hydrazinylnicotinoyl)-D-alanyl)pyrrolidin-2-yl)bo
ronic acid (HYNIC-iFAP), wherein the nitrog...
|
|
WO/2022/229519A1 |
The present invention relates to a process for hydrosilylating an unsaturated compound with a compound comprising at least one hydrogenosilyl function, catalyzed by organic gallium compounds. The invention also relates to said organic ga...
|
|
WO/2022/229234A1 |
The present invention relates to nitrogenous hetetocyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
|
WO/2022/223839A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I R1 is selected from the group consisting of hydrogen...
|
|
WO/2022/223841A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I wherein Ra is at each occurrence independently selec...
|
|
WO/2022/223847A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I wherein at least three substituents Ra are selected ...
|
|
WO/2022/223844A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule has of a structure of formula I Formula I wherein n, m, p, q are integers selecte...
|
|
WO/2022/224469A1 |
Provided are a phenylboronic acid compound that can impart to a polymer the ability to reversibly change physical properties when exposed to water, a polymer that exhibits reversible changes in physical properties when exposed to water, ...
|
|
WO/2022/224151A1 |
The present invention relates to new fluorescent markers selectively binding tau protein, uses thereof, methods for imaging the neurofibrillary tangles of the tau protein in the retina of a subject, as well as a device that enables the i...
|
|
WO/2022/223846A1 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule comprises or consists of a structure represented by (formula I) Ra is at each occ...
|
|
WO/2022/223840A1 |
The invention relates to an organic molecule, in particular to its application in optoelectronic devices. According to the invention, the organic molecule has a structure of formula I (I) wherein n, m, p, q are integers selected from 0 a...
|
|
WO/2022/223843A2 |
The invention relates to an organic molecule, in particular for the application in optoelectronic devices. According to the invention, the organic molecule comprises or consists of a structure represented by formula I wherein R1 is selec...
|
|
WO/2022/220696A1 |
Described herein is a process for hydroarylation of an olefin to obtain an alkylated benzene product. The process involves reacting an olefin compound of formula II with an arene compound of formula III in the presence of a lanthanide co...
|
|
WO/2022/220453A1 |
The present invention provides a novel compound and an organic light-emitting device comprising same.
|
|
WO/2022/220285A1 |
A hardener comprising a pyridinium salt, wherein the pyridinium salt has a benzyl group at the 1-position and has an electron-attracting group at the 2-position, the benzyl group having an electron-donating group; an adhesive composition...
|
|
WO/2022/218562A1 |
A metal-organic coordination compound, which is neutrally charged and wherein the coordination compound comprises at least one divalent lanthanide coordinated by a cyclic organic ligand, wherein the cyclic organic ligand contains two mon...
|
|
WO/2022/218328A1 |
A boric acid derivative of a β-lactamase inhibitor as represented by formula I, or a pharmaceutically acceptable salt thereof, and a stereoisomer and a rotamer or a tautomer or a deuterated compound of the derivative and salt. The boric...
|
|
WO/2022/215541A1 |
The purpose of the present invention is to provide a light-emitting element material with which it is possible to obtain a light-emitting element having excellent element efficiency and durability, and a photoelectric conversion material...
|
|
WO/2022/217010A1 |
The present disclosure relates to bifunctional compounds that serve as degraders (and/or inhibitors) of the estrogen receptor (target protein). In the present disclosure, the bifunctional compounds, which contain a target protein (estrog...
|
|
WO/2022/213993A1 |
A composition, comprising an organic compound H as a host material, a luminous body E having a structure represented by chemical formula (1) or (2), and an organic resin. The organic resin is used to form a film by printing or coating, a...
|
